The study of antithrombotic efficacy, safety and tolerability of aspirin generic in patients with coronary heart disease
The aim of the study was to investigate the antithrombotic efficiency, safety and tolerance of Lospirintm in patients with coronary artery disease. The study involved 50 patients (32 men and 18 women) aged 40-65 years with disease duration from 3 to 27 years, receiving daily one tablet of Lospirintm...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dnipro State Medical University
2013-10-01
|
| Series: | Medičnì Perspektivi |
| Subjects: | |
| Online Access: | http://medpers.dsma.dp.ua/issues/2013/N3/37-43.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850059796174077952 |
|---|---|
| author | Khomaziuk T.A. Novozhenina L.I. Levykh А.Е. Kryzhanovska S.I. Hrytsenko V.I. |
| author_facet | Khomaziuk T.A. Novozhenina L.I. Levykh А.Е. Kryzhanovska S.I. Hrytsenko V.I. |
| author_sort | Khomaziuk T.A. |
| collection | DOAJ |
| description | The aim of the study was to investigate the antithrombotic efficiency, safety and tolerance of Lospirintm in patients with coronary artery disease. The study involved 50 patients (32 men and 18 women) aged 40-65 years with disease duration from 3 to 27 years, receiving daily one tablet of Lospirintm (75 mg) for 28 days as an antiplatelet agent in addition to basic therapy. General clinical data, hemodynamic parameters, laboratory results of blood tests, urine and agregant state of blood plasma were assessed. During the period of drug application side effects/reactions were not registered. Tolerance of Lospirintm was satisfactory in 100% of patients. Drug intake for 28 days gave good antiplatelet results in 90% of patients with coronary artery disease. |
| format | Article |
| id | doaj-art-6c956a84f372466a90838c97b749fccd |
| institution | DOAJ |
| issn | 2307-0404 2307-0404 |
| language | English |
| publishDate | 2013-10-01 |
| publisher | Dnipro State Medical University |
| record_format | Article |
| series | Medičnì Perspektivi |
| spelling | doaj-art-6c956a84f372466a90838c97b749fccd2025-08-20T02:50:47ZengDnipro State Medical UniversityMedičnì Perspektivi2307-04042307-04042013-10-011833743The study of antithrombotic efficacy, safety and tolerability of aspirin generic in patients with coronary heart diseaseKhomaziuk T.A. 0Novozhenina L.I. 1 Levykh А.Е.2Kryzhanovska S.I. 3Hrytsenko V.I. 4SE «Dnipropetrovsk medical academy of Health Ministry of Ukraine»SE «Dnipropetrovsk medical academy of Health Ministry of Ukraine»SE «Dnipropetrovsk medical academy of Health Ministry of Ukraine»SE «Dnipropetrovsk medical academy of Health Ministry of Ukraine»SE «Dnipropetrovsk medical academy of Health Ministry of Ukraine»The aim of the study was to investigate the antithrombotic efficiency, safety and tolerance of Lospirintm in patients with coronary artery disease. The study involved 50 patients (32 men and 18 women) aged 40-65 years with disease duration from 3 to 27 years, receiving daily one tablet of Lospirintm (75 mg) for 28 days as an antiplatelet agent in addition to basic therapy. General clinical data, hemodynamic parameters, laboratory results of blood tests, urine and agregant state of blood plasma were assessed. During the period of drug application side effects/reactions were not registered. Tolerance of Lospirintm was satisfactory in 100% of patients. Drug intake for 28 days gave good antiplatelet results in 90% of patients with coronary artery disease.http://medpers.dsma.dp.ua/issues/2013/N3/37-43.pdfcoronary artery diseaseantithrombotic agentlospirin |
| spellingShingle | Khomaziuk T.A. Novozhenina L.I. Levykh А.Е. Kryzhanovska S.I. Hrytsenko V.I. The study of antithrombotic efficacy, safety and tolerability of aspirin generic in patients with coronary heart disease Medičnì Perspektivi coronary artery disease antithrombotic agent lospirin |
| title | The study of antithrombotic efficacy, safety and tolerability of aspirin generic in patients with coronary heart disease |
| title_full | The study of antithrombotic efficacy, safety and tolerability of aspirin generic in patients with coronary heart disease |
| title_fullStr | The study of antithrombotic efficacy, safety and tolerability of aspirin generic in patients with coronary heart disease |
| title_full_unstemmed | The study of antithrombotic efficacy, safety and tolerability of aspirin generic in patients with coronary heart disease |
| title_short | The study of antithrombotic efficacy, safety and tolerability of aspirin generic in patients with coronary heart disease |
| title_sort | study of antithrombotic efficacy safety and tolerability of aspirin generic in patients with coronary heart disease |
| topic | coronary artery disease antithrombotic agent lospirin |
| url | http://medpers.dsma.dp.ua/issues/2013/N3/37-43.pdf |
| work_keys_str_mv | AT khomaziukta thestudyofantithromboticefficacysafetyandtolerabilityofaspiringenericinpatientswithcoronaryheartdisease AT novozheninali thestudyofantithromboticefficacysafetyandtolerabilityofaspiringenericinpatientswithcoronaryheartdisease AT levykhae thestudyofantithromboticefficacysafetyandtolerabilityofaspiringenericinpatientswithcoronaryheartdisease AT kryzhanovskasi thestudyofantithromboticefficacysafetyandtolerabilityofaspiringenericinpatientswithcoronaryheartdisease AT hrytsenkovi thestudyofantithromboticefficacysafetyandtolerabilityofaspiringenericinpatientswithcoronaryheartdisease AT khomaziukta studyofantithromboticefficacysafetyandtolerabilityofaspiringenericinpatientswithcoronaryheartdisease AT novozheninali studyofantithromboticefficacysafetyandtolerabilityofaspiringenericinpatientswithcoronaryheartdisease AT levykhae studyofantithromboticefficacysafetyandtolerabilityofaspiringenericinpatientswithcoronaryheartdisease AT kryzhanovskasi studyofantithromboticefficacysafetyandtolerabilityofaspiringenericinpatientswithcoronaryheartdisease AT hrytsenkovi studyofantithromboticefficacysafetyandtolerabilityofaspiringenericinpatientswithcoronaryheartdisease |